[1]
R. P. Swain, P. Shilpa, and S. Panda, “ETHICAL GUIDELINES AND STUDY DESIGN FOR BIOAVAILABILITY AND BIOEQUIVALENCE STUDY”, Asian J Pharm Clin Res, vol. 8, no. 6, pp. 28–33, Nov. 2015.